Invea Therapeutics
Salvatore (Salvo) Alesci has served in various high-level roles in the pharmaceutical and healthcare industry, including as SVP at National Minority Quality Forum and Chief Scientific Officer at Invea Therapeutics. With a strong background in scientific and regulatory affairs, Alesci has demonstrated expertise in leading multidisciplinary teams and driving innovative research initiatives. Alesci's educational background includes a PhD in Experimental Endocrine and Metabolic Sciences and an MD from Università degli Studi di Messina.
This person is not in any offices
Invea Therapeutics
1 followers
Invea Therapeutics focuses on the discovery of transformational therapeutics for inflammatory gastrointestinal and hepatobiliary disorders.